Trials / Completed
CompletedNCT00497744
A Pharmacokinetic Study of Cefepime After Administration Into Dialysate in Patients With Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis
Research Study on the Pharmacokinetic Profile of Intraperitoneal Cefepime in Patients With Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (estimated)
- Sponsor
- Hospital Authority, Hong Kong · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Cefepime is a broad-spectrum antibiotic used in treating CAPD peritonitis. However, medical knowledge has been lacking with regard to its pharmacokinetic profile after it has been administered intraperitoneally. The current study aims at determining the drug level at different time after the drug has been added into the peritoneal fluid in patients with CAPD peritonitis. The results of this study will finally leads to rational prescription of this drug at correct dosages.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intraperitoneal Cefepime |
Timeline
- Start date
- 2005-11-01
- Completion
- 2007-12-01
- First posted
- 2007-07-09
- Last updated
- 2011-06-16
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00497744. Inclusion in this directory is not an endorsement.